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Abstract
Due to the great amount of information generated and supported by the explosive evolution of computer science systems 
since the end of the last century, the expansion and transference of scientific knowledge has caused a rapid transformation 
of scientific discoveries in products and applications that have positive effects in the life quality of societies.   Today, a 
great amount of data in medicine is obtained by the application of biotechnological methods that constantly evolve. Thus, 
scientific research related to diabetes keeps improving.   In this context, productivity and competitiveness must be sustai-
ned on knowledge which facilitates and encourages organizational innovation capacity.   For this reason, knowledge based 
systems emerge as a useful tool to help organizations solve difficult assignments or improve their processes.   In this work, 
derivate from known diabetes group of symptoms and interactions that diabetes research maintains with the biotechnolo-
gical processes, the authors carried out a brief analysis of the knowledge involved as well as the role that knowledge-based 
systems have played, and keep playing in support of them.    Additionally, with the systemic perspective obtained by the 
authors regarding aspects like knowledge, practices and resources needed in clinical and laboratory practices, they propose 
a systemic model that can support diabetes research and clinical process.
Keywords: biotechnological process, computer science systems, diabetes, knowledge based systems, systemic.
Resumen
Debido a la gran cantidad de información generada y apoyada por la evolución explosiva de sistemas de la ciencia compu-
tacional, desde finales del siglo pasado, la expansión y transferencia de conocimiento científico ha provocado una rápida 
transformación de los descubrimientos científicos en productos y aplicaciones que afectan positivamente la calidad de vida 
de las sociedades. Actualmente, una gran cantidad de datos en medicina se obtiene por la aplicación de métodos biotecno-
lógicos que constantemente evolucionan. De igual manera, la investigación científica sobre diabetes mantiene una mejora 
constante. En este contexto, tanto la productividad como la competitividad se deben apoyar con conocimiento que facilite 
y promueva la capacidad de innovación organizacional. Por esta razón, los sistemas basados en conocimiento emergen 
como una herramienta útil para coadyuvar con las organizaciones en la solución de situaciones difíciles o en la mejora 
de sus procesos. En este trabajo, derivado del conocido grupo de síntomas y de las interacciones que la investigación en 
diabetes mantiene con los procesos biotecnológicos, los autores realizan un breve análisis del conocimiento implicado 
y del rol que los sistemas basados en el conocimiento han desempeñado, -y continúan desempeñando, en apoyo a tales 
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Introduction
Nowadays, information must be not only effective but 
efficient which would grants possibility to emerge as 
one of the key success factors using strategies and tac-
tics to  assure products or services quality that clients 
need. Therefore, the evolution of computer science 
has allowed the appearance and evolution of systems 
that facilitate the elicitation, classification, codification, 
storage, maintenance and update of the necessary in-
formation for the organizations. It leans more on the 
knowledge acquired and developed by its personnel 
than in the classic production factors, in order to gene-
rate a major productivity. The generation of value by 
means of knowledge application and the personnel’s 
creativity allows generating strategies that affect the 
improvement of processes or products and, still more, 
in the establishment of innovation processes tending 
to support the establishment of competitive strategies.
In order to effectively support such intentions and with 
the purpose of diminishing risks, and preventing envi-
ronmental impacts, as result of high production levels. 
Biotechnology takes advantage of Artificial intelligen-
ce techniques and tools, offered by knowledge-based 
systems to support its research processes. In the case 
of biomedical research, processes have already been 
carried out on-line. This facilitates simultaneity and par-
ticipation between people located in different places, 
as well as security in the exchange of information in 
real- time. In the BVS 2007, it is mentioned that “deci-
sion making processes, practices and policies, must be 
sufficiently informed by scientific evidences, such as va-
riability in standards of information use, the capacity to 
get knowledge and the decision to react for getting new 
knowledge”.
It is not omitted that web-blogs (or weblogs) encoura-
ge writing and distribution of images and ideas. Ündey 
et al., (2003), estimate that on-line process monitoring 
techniques could be extended to include predictions 
of end of batch quality measurements during the pro-
gress of a batch run. In the same way, process moni-
toring, quality estimation and fault diagnosis activities 
could be automated and supervised by embedding 
them into a real-time knowledge-based system (RTKBS). 
Likewise, knowledge-based systems utilize acquired 
human expert knowledge in a computer, with the pur-
pose of obtaining, storing and sharing this expertise 
(as well as knowledge extracted from databases or got 
from external sources) in order to be on hand for non 
experts.
Among different applications of knowledge-based sys-
tems, it is possible to find applications such as diag-
nosis, planning, designing, monitoring and control 
of processes, or training and consultation services. 
Therefore expert systems that focus onto support or-
ganizational making decisions are equipped with com-
ponents denominated knowledge-based management 
subsystems. Thus, taking advantage of the characte-
ristics of these systems and the contribution that can 
be obtained from them in a knowledge management 
system, with the systemic perspective obtained by the 
authors and regarding aspects like knowledge, prac-
tices and resources needed in clinical and laboratory 
practices, the authors design and propose a systemic 
model that can support diabetes research and clinical 
process.
Diabetes’ aspects
Diabetes is recognized like syndrome because it com-
bines a symptoms series. If diabetes does not stay down 
under control, it can generate very serious complica-
tions to human health. The U. S. A. National Institutes 
of Health classify diabetes as “ a condition characte-
rized by hyperglycemia (high blood glucose) resulting 
from the body’s inability to use blood glucose for ener-
gy”, a disease that is characterized by alterations in the 
carbohydrates, fat and proteins metabolism, derivative 
from deficiencies in insulin secretion or its assimilation 
in the organism. With illustrative purpose and to ob-
viate time, figure 1 shown the most known group of 
symptoms related with different aspects, such as age, 
genetics, cultural and individual habits, which involved 
a wide range of scientific and empiric knowledge.
procesos. Adicionalmente, con la perspectiva sistémica obtenida por los autores respecto al conocimiento y recursos nece-
sarios en prácticas clínicas y de laboratorio, proponen un modelo sistémico capaz de apoyar la investigación y el proceso 
clínico de la diabetes.
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nal, sistémica.
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In Type-1diabetes, known also as youthful because it is 
most frequently diagnosed in children or young people, 
pancreatic cells produce little or no insulin.   Never-
theless, symptoms are detected, usually, when the gly-
cemia levels are already low. According to Mexican 
Institute for Social Security, this type of diabetes pro-
vokes that the body unknowns own tissues and tries to 
destroy them; it attacks its insulin-producer cells (beta 
cells). So the metabolism of proteins, fat or carbohydra-
tes cannot be carry out in an appropriate way because 
of the lack of insulin.
According to Koschorreck and Gilles (2008), Type-1 
diabetes mellitus results from defective pancreatic insu-
lin secretion; meanwhile, insulin resistance, obesity and 
type-2 diabetes mellitus may result from defects in the 
insulin signaling system and are often accompanied by 
abnormalities in insulin degradation. Although Type-1 
diabetes is not curable, it can be under control; none-
theless, if patient has not adequate care of it, he could 
go into a cetoacidotic mortal coma. Besides an appro-
priate diet and exercising, it is necessary patients main-
tain control of both arterial pressure and cholesterol, 
trying to get glucose at non-diabetic levels.
Taking into account that common clinical experience 
has shown that multiple injections on the same subject 
often exhibit varying effects (between-day as well as wi-
thin-day), possibly depending on the time of the day or 
on the site of injection; Clausen et al., (2006) studied 
the pharmacokinetics of biphasic insulin aspart admi-
nistered by multiple subcutaneous injection, focusing 
into assess the magnitude of the inter-and intra-subject 
variation in the kinetics. He mentioned, in subjects 
with Type-1 diabetes, exogenous insulin is necessary 
for regulation of glycaemia. So, optimal control would 
reduce hyperglycaemia, which may cause long-term 
microvascular damage, blindness, renal impairment 
and peripheral neuropathy; it would also reduce the 
risk of life-threatening hypoglycaemia. 
In Type-2 diabetes, organisms present the condition 
known as insulin resistance, causing that liver, muscle’s 
cells or fats do not absorb sugar from blood to get ener-
gy; such that, this rejection increases blood sugar le-
vels (hyperglycemia). Pancreas does not have enough 
capacity to produce the needed insulin. A most fre-
quent issue in overweight people, without forgetting 
risks produced by age, genetic propensity or personal 
habits, such as feeding and sedentary lifestyle. Injec-
table medicines, as exenatide and pramlintide, can 
lower glycaemia levels. According to MedlinePlus (de-
pendent on U. S. Medicine National Library), patients 
must try to maintain their arterial pressure at 130/80 
mm/Hg, or less. Among cares patients must take of 
themselves, it is possible to mention some like get pe-
riodical checkups for kidneys, hemoglobin, choleste-
rol, triglycerides, feet or teeth. It should be noted that 
Figure 1.  Diabetes types and symptoms 
(personal elaboration, according with information obtained from Medline Plus)
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in world death causes, an outstanding issue is that pro-
voked by Type-2 diabetes derived from cardiovascu-
lar complications, which could be diminished if there 
existed an adequate resource that allowed diagnosing, 
treating and educating patients with respect to their cli-
nical controls and personal habits. This condition was 
endorsed by Lincoln et al., (2008) they developed a 
mathematical model to determine the effect of a foot 
care education programme in the secondary preven-
tion of foot ulcers. Thus, they concluded that although 
they could not document a benefit from their particu-
lar intervention chosen for study, they consideres that 
every effort should continue to be made to ensure 
that patients with healed ulcers reduce risk associated 
behaviour as much as possible. As mentioned before, 
diabetic patients should be conscious about lipids and 
arterial tension control as well as their exercising and 
nutritional habits.
On one hand, taking advantage that US Food and 
Drug Administration has approved exenatide for the 
treatment of Type-2 diabetes in adult patients who have 
not achieved adequate glycaemic control and who are 
taking metformin, or sulfonylurea, or a combination 
of both, Nauck et al., (2007) found out that exenati-
de provides overall glycaemic control comparable to 
premixed insulin, and has the added benefit of weight 
reduction. It is convenient to mention that the parti-
cipants in the case study were generally overweight. 
On the other hand, Dashora (2009), comparing blood 
glucose control when patients used biphasic insulin 
aspart (BIAsp) three times a day (using 70/30 high-
mix before breakfast and lunch), with biphasic human 
insulin (BHI, 30/70) twice daily in adults with Type-2 
diabetes already treated with insulin; he found out that 
an insulin regimen using high-mix BIAsp (BIAsp 70) be-
fore breakfast and lunch and BIAsp 30 before dinner 
can achieve lower blood glucose levels during the day 
through reduced mealtime glucose excursions, in par-
ticular at lunchtime than a twice-daily premix regimen.
In Gestational diabetes, though symptoms usually do 
not appear (or are slight) and are not potentially mor-
tal for pregnant women, based on genetic and ethnic 
aspects (especially Latin or African) and the propensity 
to infections, and obesity, among others factors, this 
diabetes type can be detected during pregnancy. In 
order to control the glucose levels during pregnancy 
and to ensure health for her fetus and avoid potential 
problems during childbirth, mothers with this diabetes 
type have an increased risk in undergoing arterial hy-
pertension during pregnancy. However, women with 
gestational diabetes can evolve diabetes 5 or 10 years 
after child birthing which is a risk that could increase 
in obese women. In MedlinePlus, it is recommended 
that pregnant women who suffer gestational diabetes 
tend to got greater babies when being born. This can 
increase problems possibility at childbirthing. So the-
se women have got an increased risk undergo arterial 
hypertension during pregnancy. Babies could be pro-
ne to got low sugar periods in blood (hypoglucaemia) 
during the first days of their lives. Women with ges-
tational diabetes must be monitor carefully after the 
childbirth, in regular medical appointments, looking for 
diabetes signs. If women undergo to prenatal scree-
ning tests, between weeks 24 and 28 of pregnancy, 
this will support to detect gestational diabetes at just 
the right moment.
It is not omitted to mention that this type of diabe-
tes can provoke in the fetus problems like are referred 
next:
•	 Among most serious cases, it is possible to mentio-
ned baby’s death, spontaneous abortion, red blood 
cells increase (policitemia), calcium reduction in 
blood (hipocalcemia), jaundice, breathing problems 
or pulmonary immaturity. 
•	 Although less serious, if the baby receives more 
sugar than normal, by the placenta, his pancreas 
should produce additional insulin, which can cause 
that their organs and his body increase of size, ele-
vating his weight (fetal macrosomia), being able to 
weigh more than 4kg when being born. Also, when 
being born, the baby can present a high insulin le-
vel; although he has not longer receives sugar de-
rivative from the placenta, his sugar level (glucose) 
would decrease below the normal energy levels, 
generating neonatal hypoglucaemia.
•	 Also, the baby can be born with respiratory insuffi-
ciency or poor lungs development, which will re-
quire that he spends some time in some neonatal 
intensive cares unit.
According to the American Diabetes Association, ba-
bies with excessive insulin could be children with obe-
sity risk and adults with the risk for developing Type-2 
diabetes.
To Chu et al., (2007) numerous studies in the U.S. and 
elsewhere have reported an increased risk of gestatio-
nal diabetes mellitus (GDM) among women who are 
overweight or obese compared with lean or normal-
weight women. So, it has been suggested that the re-
lationship between decreased insulin sensitivity and 
excessive fetal growth in obese women and women 
with this type of diabetes may explain some of the in-
creased incidence of obesity and glucose intolerance 
in their offspring. As an outcome of their study, these 
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authors concluded that high maternal weight is asso-
ciated with a substantially higher risk of gestational dia-
betes mellitus, compared with normal-weight pregnant 
women. So, women with GDM are associated with a 
higher risk of developing Type-2 diabetes later in life in 
both the mother and child. In addition, Rowan et al., 
(2008) mention that Gestational Diabetes is a compli-
cation in about 5% of pregnancies; also, they mentio-
ned that Metformin is a logical treatment for women 
with gestational diabetes mellitus; besides women 
preferred Metformin to insulin treatment. Though Me-
tformin is more acceptable to women with gestational 
diabetes mellitus than is insulin, Metformin crosses the 
placenta and could affect fetal physiology directly. As 
an outcome of their study, they found out that women 
receiving combined treatment required less insulin and 
gained less weight than those taking insulin alone. So, 
they concluded that in women with gestational diabe-
tes mellitus, Metformin (alone or with supplemental 
insulin) is not associated with increased perinatal com-
plications as compared with insulin
Insipid diabetes appears when kidneys are no longer 
able to retain water while filtering blood. So, derivative 
of this affection it is possible to find the types listed 
next:
•	 Central Insipid, motivated by a small amount or 
lack of the anti-diuretic hormone  known as vaso-
pressin, which limits the urine amount produced by 
the organism,  causing the individual to drink large 
amounts of water to compensate the loss of  water 
in his or her body,
•	 Nephritic (nephrogenous) Insipid, caused when 
kidneys are not able to respond to the vasopressin 
action, triggering the kidneys to release excessive 
quantities of water in the urine and the individual 
tinkles very much. Although it can depend on con-
genital origins, this type of diabetes can be pro-
voked by some drugs, urinary obstructions or low 
levels of calcium or potassium.
Engkilde, Menné and Johansen (2006) investigating 
whether environmental exposure to chemicals lea-
ding to contact allergy could influence the risk of 
Type-1 diabetes, they found an inverse relationship 
between contact allergy and Type-1 diabetes. Howe-
ver, Piątkiewicz, Czech and Tatoń (2007) stated that in 
diabetic patients, infections take a more severe course 
and complications occur more often because previous 
studies have shown that diabetes is a pathological sta-
te that influences immunity.
It is not omitted to highlight the importance of a nu-
tritive diet and the necessity to exercise that patients 
with diabetes must implement in themselves, in order 
to prevent harms, such as depression which could 
lead patients to take poor care for themselves, as was 
analyzed by Paile-Hyvärinen, Wahlbeck and Eriksson 
(2007), who observed that Depression is prevalent in 
people with Type-2 diabetes and affects both glycae-
mic control and overall quality of life. This was con-
firmed by Chernyak et al., (2009) they found out that 
depression and elevated depression symptoms are 
more prevalent in patients with Type-2 diabetes than 
in those without diabetes. 
To Nielen, Schellevis and Verheij (2009), the preva-
lence rate of chronic diseases like hypertension and 
diabetes mellitus is rapidly increasing, particularly in 
industrialized countries. Hypertension and diabetes 
are major risk factors for the development of cardio-
vascular and renal diseases, and could result in pre-
mature death. Correspondingly, to O´Connor (2010), 
potential for the 30-aged Electronic Health Records 
technology to improve chronic disease care remains 
unrealized (especially, care for adults with Type-2 dia-
betes). 
Biotechnological Considerations
The production of transgenic plants with nutritious, sa-
nitary and industrial interest has managed to remarka-
bly increase the quantity and rapid development of 
agricultural products, plus new varieties of plants able 
to tolerate adverse conditions and resist pesticides and 
plagues. Also, the search for less aggressive energy 
sources for the environment has led to the production 
of biofuels like ethanol, biodiesel and methane, from 
renewable sources such as agricultural debris. Falcon 
et al., (2009) have worked with Microbial Fuel Cells 
(MFC), elucidating the mechanisms of electron transfer 
between microorganisms and electrodes in order to 
get better rates of electricity production.
DaSilva et al., (2002) analyzed the way in which Bio-
technology is considered as a technological advance-
ment impulsor in both the developed and developing 
countries. They also analyzed how opportunities and 
constraints in agricultural biotechnology in develo-
ping countries are of significance in responding to po-
verty.  Additionally, they review the establishment in 
several developing countries of biotechnology parks 
and showed them as examples of pro-poor biotech-
nology and pro-industrial programs for development. 
Bustamante and Bowra (2002) taking into account that 
knowledge-based industries have became major com-
ponents of leading world economies visualize how in-
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dustries in Latin American countries have to confront 
a lack of investment so that these countries are not 
achieving economic growth and competitiveness in 
these sectors. This is confirmed by a study developed 
by Cordero-Mata (2009), in which it is concluded that 
in Costa Rica there is practically no evidence of crea-
tion of companies based on technologic and this coun-
try is a technology receiver, with certain development 
on clusters of high-tech companies, such as manufactu-
ring of medical devices, like electronic and automotive 
components. Nevertheless, university-industry relation-
ships are weak, in spite of institutional changes, whe-
reas more frequent technology transference is found 
through consultancy and researching contracts. Also, 
Gomez and Rodriguez (2008) found that in Mexico, 
although governmental programs state regulations to 
foster biotechnology, there are no strong links bet-
ween industry and universities, such that, local resear-
chers tend to pursue basic projects of general nature 
and do not focus on the specific needs of the Mexican 
market. In this context, taking advantage of that small 
and medium enterprises have a high impact in their 
local economies, they analyzed the way to boost the 
potential of the so called High-Technology Small and 
Medium Enterprises (High-TECH SME’s), which include 
not only R&D based new products and services but 
also improved designs and processes and the adoption 
of new technologies.   This allows both at national and 
global levels generating and accessing new technolo-
gies, especially Biotechnology. So, they give significant 
importance to clustering to gain access to new ideas 
and tacit knowledge, especially in young industries 
and governments commitment to project financing.
According to Saigí-Rubió and Lopez-Sevilla (2004), 
throughout history, science and technology have been 
key elements for human development, whereas today 
they are regarded by many people as the next great 
revolution of the knowledge economy. Thus, in the 
bio-security scope, it is no longer novel to hear about 
the use of cantilevers and the appearance of water and 
oil nanoemulsions to monitor and detect bacteria and 
virus in the environment, besides powerful tools for 
the manipulation of cellular behavior in the treatment 
of diseases and in the always new field of tissue en-
gineering. In this sense, a work has been developed 
by Voronov et al., (2009), modeling the flow behavior 
inside the space pore within scaffolds, using Poly-L-
Lactic Acid (PLLA) and leaching salt with various grain 
size salt combinations. Therefore, within the research 
approaches like these it can be found:
•	 medicine effectiveness and security improvement,
•	 tumor detection nanocapsules’ development,
•	 dendrimers for cancer treatment,
•	 nanometric biosensors to detect phenols, methane 
or carbon monoxide, to support environmental con-
trol,
•	 artificial cellular membranes for tissue restoration; 
so, better results can be obtained, by means of the 
robotic surgery support,
•	 better cut tools, since coal nanotubes are harder 
than steel,
•	 derivative products from petroleum used in diver-
se ways in mining operations, since certain natural 
enzymes, coming from microorganisms, plants and 
animals can be used to catalyze chemical reactions 
with high efficiency and specificity,
•	 biodegradable polymer development to diminish 
environmental pollution,
•	 biodegradable materials for use in surgery and im-
plantation tissue (epithelial, bony),
•	 solar protectors, cosmetic products or food conser-
vative containers,
Experimentally, Vanegas-Córdoba et al., (2004), eva-
luate an economic alternative to produce xilitol, al-
ternative sweetener (with similar characteristics to 
sucrose) that appears for diabetics’ use. Also, Redi 
(2008) mentioned that staminal cells from human fatty 
tissue acquired cardiomiocit after its transitory expo-
sure to a rat cardiomiocitic, which indicates the pos-
sibility of an efficient reprogramming of somatic cells 
between different species.
By injections of human bony staminal cells to diabetic 
mice, it has been repaired the mice producer insulin 
cells. It is important to mention that the Helsinki De-
claration, written in 1964 by Worldwide Medical Asso-
ciation, in Finland, displays justification and principles 
to realize clinical investigations in humans. Saigí and 
Lopez (2004) mention that “nowadays, modern biote-
chnology is meant like a multidisciplinary science that 
includes molecular genetics, chemical and process en-
gineering, animal and vegetable anatomy, biochemistry, 
microbiology, immunology, cellular-biology, agriculture, 
electronic and computer science, among many other 
sciences However, one of the problems biotechnolo-
gy faces is rejection” . Although therapies with antibo-
dies represent one of the most promising sectors in 
the pharmaceutical industry, whose annual sales rea-
lize thousands of million dollars, commercialization of 
genetically-modified products causes great preoccupa-
tion. This is due to uncertainty about negative effects 
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on humans health and nature balance. People think 
that transgenic species would have more competitive 
advantages and, therefore, major possibilities of domi-
nating natural communities, causing structural chan-
ges in natural ecosystems, injuring fauna or affect the 
health of humans which is unacceptable in the field 
of social ethics. In this context, Bioethics is meant in 
a special way where globalized ethics which involve 
great amounts of information (generated by internatio-
nal standards), brings about knowledge networks and 
the innovation clusters emergence, where computer 
science and knowledge-based systems play, again, an 
important role.
With the support of molecular biotechnology, 
knowledge handling, and control of staminal cells, it 
could be replaced bony marrow therapy in many can-
cers and other treatments, offering new alternatives for 
tissue and organ substitution to treat degenerative di-
seases. Also, cellular cloning technology allows produ-
cing embryos in a way that, Felmer (2004) establishes 
cattle farmers would increase their herd performance 
in only one generation, since cellular cloning allows 
producing embryos from an ovum, without spermato-
zoa. With such embryos staminal cells can be obtained 
(pluripotentials) from an individual, to develop human 
tissues able to cure diseases like diabetes, Parkinson 
and Alzheimer syndromes or certain medullar injuries, 
diminishing rejections that could be produced in trans-
plants.
Taking advantage of the close relations at present 
maintained by Biotechnology with Nanotechnology, it 
has been possible to develop medicinal products and 
medical procedures that allow optimizing health and 
life quality of societies. Nanosensors and nanoparticles 
could help in disease diagnosis and treatment, such 
as cancer, diabetes or viral disease.   So nanosensors 
could be implanted in humans to measure emissions. 
On one hand, Ozaydin-Ince et al., (2011) have crea-
ted particles, called microworms, with cylindrical sha-
pe coated with a biocompatible porous membrane to 
create fluorescent sodium sensors for use as in vivo 
sodium concentration detectors after subcutaneous 
injection. However, these hollow nanoparticles could 
be implanted under human skin and remain anchored 
at its original location to monitor levels of glucose. So 
people with diabetes could check their blood sugar by 
glancing at an area of their skin. On the other hand, 
Mann et al., (2010) state that, genic therapy can be 
bear in mind to envisage a new approach or promising 
tool in the search of a treatment for diabetes, because 
advances in the genic therapy field allow to dispose of 
safer and effective vectors to transfer genes of interest 
to different cells or tissues of the organism. Recently, 
the evolution of biotechnology and its interactions with 
nanotechnology has proved that medicine production 
by biotechnological methods (replacing traditional 
procedures) is a reality, as well as being safer and more 
economical. Multiple fuse sensors for detecting a wide 
rank of pathogens and indicating guests will be able 
to offer the highest detection capacity. Therefore, it is 
not strange that today people talk about biochips to 
determine correlation between gene expressions and 
different congenital diseases, at the moment without 
cure. It is possible that responsible genes for some di-
seases can be identified. Protein handling and control, 
in response to the necessity to obtain great amounts of 
deficit proteins for hospitals have channeled investiga-
tions towards the transgenic animal use as bio-reactors 
(live reactors). Animals produce in their cells the ne-
cessary proteins for humans, as it is the case of cows, 
sheep and goats in which human gene cells are intro-
duced, into their milk producer cells to codify proteins 
of therapeutic interest. Thus, important amount of the 
desired protein are developed which can be very use-
ful for both new born babies, old or sick people.
Beltrán-Fernández et al., (2010) are working to optimi-
ze the actual surgical technique, analyzing the diffe-
rences between the biomechanical effects on a bone 
graft, which replaces a damaged C4 vertebral body, 
a titanium alloy (Ti6A14V) cervical plate, used to iso-
late the C4 damaged vertebra, and the influence on 
the compressive loads on the complete and instru-
mented C3-C5 cervical model. In the same context, 
Merchán-Cruz et al., (2007) published a work related 
to the development of an algorithm to improve the 
performance of manipulating robots which could su-
pport the development of a prosthesis as previously 
mentioned. Moreover, as coal nanotubes are much 
more resistant than steel, it is possible to design and 
build a prosthesis as seen in the research developed by 
Colombo and Vergani (2009), who experiment with a 
prosthesis to improve an athlete’s performances.
Knowledge-Based Systems (KBS)
Among all the characteristics that identify knowledge-
based systems, these systems support their performan-
ces over quality and quantity from specific domain 
knowledge rather than techniques to solve problems. 
Nonetheless, these systems provide useful applica-
tions when needed to solve very complex problems. 
Mostly, when organizations need to acquire and pre-
serve specific expert knowledge, in order to share with 
non-experts the ability to explain reasoning processes 
applied in solving problems. Likewise, knowledge-
based systems may maintain operative interactions 
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with other systems in a way that, eventually, they need 
information imported from other systems or, on the 
contrary, knowledge-based systems’ results could be 
exported to other systems, in order to be treated.
Richards (2003) has stated that an explanation is 
important for knowledge-based systems as it satis-
fies users’ necessities to decide whether to accept 
or reject a recommendation. Since it is not possible 
to know what goes on inside an expert’s head, the-
re is no way to accurately capture thought process 
and reason. So, using browsing tools to explore the 
knowledge of different views, the what-if analysis for 
case values and the display of rules and traces in 
a number of alternative formats give users control, 
linked to greater satisfaction and acceptance. Mal-
hotra (2006) defines, “...Knowledge management 
systems engineering seeks model management so-
lution to challenging problems involving the mani-
pulation of complex metadata artifacts, or models… 
” . Many systems that manage knowledge use seve-
ral Artificial Intelligence methods and tools, such as 
neural networks, intelligent agents or fuzzy logic, in 
order to carry out activities related with knowledge 
identification, knowledge engineering, tacit-to-expli-
cit knowledge transfer, and so on.
The evolution of decision support systems tech-
nology and its amalgamation with many other te-
chnologies such as knowledge-based techniques, 
object-oriented systems, intelligent agents, neural 
networks, genetic algorithms, as well as data ware-
housing and web-based technology, has led to 
many sophisticated knowledge-based systems (KBS) 
and modeling environments emerging. Farley et al., 
(2008) defined artificial neural network as “ a ma-
thematical model aimed to function like the neural 
network in the human brain, and is able to map in-
put data to the appropriate output data... often used 
as pattern classifiers or as function approximator”. 
Also, among different applications of knowledge-ba-
sed systems, it is possible to find applications such 
as diagnosis, planning, design, monitoring and pro-
cess control, training and consultation services as is 
shown next. Boucher (2010) considers that techno-
logy is shifting knowledge; so, asking the question 
“how can we as providers embrace technology in our 
relationships with patients and use it to improve our 
communication with them?”, he states that practitio-
ners see the advantages of efficiency and accessibi-
lity but often feel concerned by how each tool may 
overwhelm them as patients seek or gain access to 
misleading information.
Applications of Knowledge-Based Systems (KBS)
Knowledge Management (KM), initiated after World 
War II and reinforced at the end of the last century, 
is characterized by focusing on intangible assets and 
knowledge value generation, known as intellectual 
capital, as well as taking advantage of other systems’ 
utilities (mainly on information and communication 
technologies). These systems show great application 
in all organizational sectors, such as governmental, 
scientific, industrial, educational, and so on, in order to 
facilitate decision making processes. Also, it is recog-
nized as one of the main factors for knowledge-based 
systems. Groot et al., (2005), based on the idea of de-
gradation studies, argue that KBS’s abilities to deal with 
missing or invalid data is an essential dimension of KBS 
validation and the need for quantitative analysis of the 
KBS quality. Thus, in an expository but non limitative 
way, some applications are mentioned that are possi-
ble to find in the globalized world.
A. Management
In order to improve strategic, tactic or operative pro-
cesses, these systems are advocated in retrieving, ma-
naging and sharing information stored in databases 
needed for:
•	 Minimizing or reducing operation costs, offering im-
provement in planning, coordination and control of 
complex activities,
•	 Homogenizing and clarifying specialized informa-
tion, including that needed for training,
•	 Evaluating or explaining decision making.
Based on a business trip approval process, Lee et al., 
(1999) proposed a knowledge-based approach for 
workflow modeling, concluded that Knowledge Wor-
kflow Management was useful because it proved a 
useful framework to implement fully automated wor-
kflow and to improve organizations that frequently 
change their business processes under turbulent orga-
nizational environments.
B. Consultancy
This knowledge-based systems activity includes disci-
plines such as medicine, jurisprudence, engineering, 
and so on, supporting organizations to use and control 
growing information volumes. They allow organizatio-
nal workers to:
•	 Access information from experts, consultants or ex-
ternal sources,
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•	 Modeling or simulating situations, problems or sys-
tems,
•	 Interpreting or explaining legal dispositions,
•	 Report elaboration, as well as updating operative 
information.
Brézillon and Brézillon (2008) state the lack of explicit 
context representation as one of the reasons for failu-
res in many knowledge-based systems. So, they propo-
se contextual graphs for uniform reasoning elements 
representation and contextual elements 356 at the 
level of links between contextualized reasoning ele-
ments that are organized in graphs like a nest of dolls, 
with no hierarchy. Thus, they infer that a contextual 
element may itself be a contextual knowledge piece 
(where more-basic contextual elements intervene) and 
consider that contextual graphs could facilitate repre-
senting good or bad practices, as a tool to identify and 
propose rational ways to improve human behaviors.
Many researches applied concept maps on knowled-
ge management as a knowledge management tool. So 
that, concepts can be captured and queried, as well 
as connections among knowledge elements could be 
discovered. Thus, Wang et al., (2008), present a self-
associated concept mapping (SACM) in which they 
extend the use of mapping concept by proposing the 
idea of self-construction and automatic problem sol-
ving to traditional concept maps, in order to give the 
idea of concept maps with self-construction ability and 
automatic problem-solving ability. 
C. Production
In order to improve activities related with production 
and manufacturing processes, such as machinery ope-
ration, quality control, stock inventories, and so on; 
knowledge-based systems sustain organizational per-
formances by means of:
•	 Optimizing control and coordination of processes, 
as well as updating, communicating and distributing 
operative procedures,
•	 Forecasting objectives, goals or results related with 
production, including complex processes.
Csaszar et al., (2000) presented a project conducted 
for the purpose of optimizing an automated modular, 
high-speed multi-station, in order to minimize the pul-
se rate (i.e. time elapsed between the completion of 
two consecutive boards) and the number of feeder 
mechanisms required. They conclude that using the 
knowledge-based system in conjunction with the simu-
lator, factory engineers were able to produce results 
that increased production considerably and decreased 
feeder slot usage.
Relating to the biochemical industry field, Régis et al., 
(2008) proposed a non-model based method of phy-
siological state identification, based on segmentation 
of bioreactor sensors signals, in which the method is 
supported by the detection of signal singularities by 
the Maximum of Modulus of Wavelets Transform and 
the characterization by the Hölder exponent evalua-
tion. Meanwhile, physiological states characterization 
was based on the correlation product between bioche-
mical signals and, according to the results confirmed 
by microbiology experts. The authors deduce that their 
method could help to automatically control and opti-
mize the analyzed bioprocess. 
D. Financial Management
Perhaps one of the most demanding applications is 
involved in the financial world, because of the impor-
tance and complexity of this process, related to bank 
loans, financial accounting or auditing, stock exchan-
ge, and so on. In this context, it is necessary to hold 
intelligent tools that allow organization planning, con-
trolling and evaluating different and complex existent 
systems, as well as the operational and financial effects 
derived from this process.
Sun and Li (2006) saw neural networks as a black-box 
whose structure weight values is the hidden knowled-
ge for classification, which is difficult for ordinary inves-
tors and finance majors to understand. However, with 
the development of information technology, machine 
learning, and artificial intelligence, data mining appears 
and grows, in order to support detailed researchers to 
depend on reliable methods for financial distress pre-
diction, because data mining dynamically mine out 
valuable hidden knowledge, which could be applied 
to predict listed companies’ financial distress. In this 
context, the authors conclude that the decision tree 
can overcome lack of dynamic learning ability and un-
derstanding, in order to effectively predict listed com-
panies’ financial distress.
E. User’s behavior
Nowadays, it is a common practice for people to get 
different types of information from the Internet; so, in 
a similar way, activities related with the use of Internet, 
such as entertainment, publicity, sales, and so on, are 
supported by knowledge-based systems with efficient 
and adequate tools, in order to know, evaluate, and 
update information related with their market position. 
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Likewise, organizations could evaluate and control 
their programs related with assistance or customer 
services and control and evaluate their virtual environ-
ments or user’s behavior when they are connected.
Taking advantage of the convergence of fuzzy logic te-
chniques and Internet, Sedbrook (1998) described ar-
chitecture and a prototype for developing, delivering, 
and maintaining expert systems on the World Wide 
Web. On the other hand, looking for reduction of data 
needed for conclusions, Ghalwash (1998) developed 
an inference engine supported by a connectionist 
knowledge base, so, he concluded that knowledge-ba-
sed neural networks (KBNN) could be used as expert 
system knowledge bases.
Huang and Hsu (2006) designed a prediction-based 
proxy server used to improve hit ratios of accessed do-
cuments. The architecture of which consists of three 
functional components such as a log file filter, an ac-
cess sequence miner, and a prediction-based buffer 
manager. They present a development to take appro-
priate actions such as document caching, document 
pre-fetching, and even cache/prefetch buffer size, ad-
justing to achieve better buffer utilization. Finally, the 
authors report that, through simulation, they found that 
their approach had a better performance than others 
in quantitative measures, such as hit ratios and byte hit 
ratios of accessed documents.
F. Health Care
Taking into account that the number of available Web-
services increases and there is a growing demand to 
realize complex business processes by combining and 
reusing available Web-services, Argüello and Des (2007) 
concentrate one study about a services-based application 
for diagnosis and clinical management of Diabetic Retino-
pathy, where the end-users are health professionals who 
are not familiarized with Semantic Web technologies. 
Thus, they used the Ontology Web Language to encode 
domain ontology fragments and SWRL rule fragments as 
the inputs and outputs of Web services; focusing on Cli-
nical Practice Guidelines (GL) related to the biomedical 
field.  Their study highlights the benefits and drawbacks 
found when applying this approach to obtain Web servi-
ces intended to be used in clinical decision-making and 
rely on clinical practice guidelines.
Akter, Uddin and Haque (2009) showed in the 13th 
International Conference of Biomedical Engineering a 
knowledge-based system, developed with 26 rules im-
plemented using Prolog language, in order to support 
patients and practitioners in the diagnosis and manage-
ment of diabetes mellitus.
Applications of Knowledge-Based Systems in 
Biotechnological Processes
As will be notice, the use of knowledge-based systems 
as a support for Biotechnology is not recent. However, 
it takes into account the challenges that Globalization 
impose on organizations. Next is mentioned some 
works related with 449 the use of knowledge-based 
systems in biotechnological processes.
Due to availability problems shown by some key pa-
rameters involved in bioprocesses assessment; Glas-
sey et al., (1996) analyzed how knowledge-based 
systems, making an integration of software sensors 
with fundamental knowledge process could offer im-
provement in bioprocess optimization by reducing 
overall process variability and the contribution of 
human operator error. Guthke et al., (1998) consi-
dered knowledge acquisition as a major bottleneck 
with respect to efficient computer control design of 
knowledge-based systems in bioprocess engineering 
and presented their work related with the automa-
tic generation of fuzzy rules applied to data of an in-
dustrial antibiotic fermentation. Likewise, due to the 
growing importance of the bioprocess monitoring 
capabilities both in bioprocess development and phy-
siological studies, Olsson et al., (1998) focusing on 
on-line analytical systems, analyzed advantages and 
drawbacks of various of the most frequently used 
analytical techniques and components.
By trying knowledge engineering methods for chemi-
cal and biochemical process modeling and control, 
Peres et al., (2001) published their experience with an 
application into a baker’s yeast production process. 
They concluded that it was possible to obtain a more 
accurate process description when all available sou-
rces of knowledge were incorporated in the process 
model. Also, Schügerl (2001) made a review about the 
development of bioprocess engineering in the past 20 
years. He took into account advanced control, and 
used structured and hybrid models, expert systems 
and pattern recognition for process optimization, in 
order to give a report relating to the existing state of 
the art of metabolic flux analysis and metabolic engi-
neering. He concluded that Artificial Intelligence and 
knowledge-based systems were tools that made pos-
sible an organized use of schematic information and 
logical descriptions.
In simulation case studies with a bioreactor dynamical 
hybrid model that combines first principles modeling 
with artificial neural networks, Oliveira (2004) states that 
hybrid modeling through knowledge integration can 
be employed when processes are complex and poorly 
understood in a mechanistic sense, because the model 
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accuracy can be increased by the incorporation of alter-
native and complementary sources of knowledge.
Taking into account that unidimensional electropho-
resis gel analysis methods need continuous impro-
vement, Santiesteban-Toca et al., (2007), proposed a 
new algorithm to improve the performance in band 
detection and the automatic selection of lanes; con-
cluding that their procedure could be a low cost alter-
native with a good performance for the researchers 
in use of the unidimensional electrophoresis techni-
ques. Likewise, to provide efficiency and productivity 
to the powder industry, Alarkan, EsSaheb and Kamal 
(2009) presented a work in the 3rd International Con-
ference on Advanced Computational Engineering and 
Experimenting, ACEX-2009, related to the building of 
an expert system prototype which, using forward and 
backward searching techniques, acquired knowledge 
for the user to give, subsequently, recommendations 
on powder production method, satisfying the powder 
requirements for a specific application, taking advanta-
ge of a rule-based representation model.
Knowledge Management System Model 
Proposed to Support Diabetic Treatment  
and Clinical Research
Nelson et al., (2006) trying to review the performance 
and effectiveness of methods for the diagnosis, mana-
gement and treatment of infected diabetic foot ulcers 
in sources like MEDLINE, PREMEDLINE, EMBASE, AMED, 
British Nursing Index and CINAHL,  as well as internet 
registers like Controlled Clinical Trials and the National 
Research Register, in addition to nine internet sources 
for clinical guidelines or reviews and the journal “The 
Diabetic Foot”; they concluded that there was insuffi-
cient evidence on which to base any conclusions. So, 
they proposed some recommendations for further re-
search. Moreover, Aragón-Sánchez et al., (2008) taking 
into account that Osteomyelitis is one of the most fre-
quent complications of diabetic foot ulcers, they analy-
zed 185 diabetic patients with foot osteomyelitis and 
histopathological confirmation of bone involvement 
until healing, amputation or death. Thus, they found 
that osteomyelitis has different characteristics and 
prognosis if combined with a soft tissue infection. So, 
they consider that the endpoint in diabetic foot ulcers 
complicated by osteomyelitis must to be complete 
healing of the ulcer or surgical wound performed to 
treat the bone infection.
In order to obtain improvement abilities, organizations 
can take advantage of knowledge management whose 
structure allows them to systematize knowledge pre-
viously got to innovate or to solve problems. Martí-
nez-Aldanondo (2004) declares: “learning demands 
to remember”; a condition that traditional information 
systems cannot fulfill, because only human mind sto-
res cases and experiences. If expertise is shared with 
others, it can provide knowledge which, integrated in 
an adapted process of qualification and development, 
supported with suitable technologies of information, 
will promote an effective forecast culture and an effec-
tive capacity response to environment changes.
Technology would not be worthwhile for organizations 
if they did not have capable people for its use because 
they have the capacity to learn, understand and, modi-
fy methods or procedures contributed by technology. 
In this context, Artificial Intelligence has facilitated the 
appearance of systems for managing, catching, storing, 
distributing and sharing information, taking advantage 
of the specialization reached by their workers, as well 
as in the solution of either emergent or extraordinary 
events. This avoids distracting the attention of specia-
lists to routine tasks so that they can take care of major 
relevance tasks, thus improving expert personnel pro-
ductivity.
Figure 2 shows the authors’ proposal for the integra-
tion of a research and clinical structure in a knowledge 
management system, using a qualitative representation 
in which relations between the diverse factors have 
been considered. This proposal regards aspects like 
knowledge and practices, as well as resources that cli-
nical and laboratory practices must utilize, taking into 
account that they can define and document the spe-
cific and necessary knowledge for their key activities.
Diabetes’ research and treatments generate a lot of in-
formation related with symptoms, diagnosis procedu-
res, treatments’ results and progress, new discoveries 
about medicines, methods, techniques, procedures 
and interactions with other disciplines (such as Bio-
technology and Nanotechnology advances). The pro-
posed model integrates interactions between human 
capital and structural capital. Such as use, maintenan-
ce or improvement of methodologies, data reposito-
ries and information technologies that are generated in 
the daily work, in order to support the organizational 
productivity and competitiveness. 
It is not omitted to mention that this model, indepen-
dently of the knowledge-based system utilized (illustra-
ted in figure 2 as expert system), it involves the main 
processes related with an organizational knowledge 
management system, such as:
•	 Knowledge necessities identification,





•	 Knowledge base maintenance.
Furthermore, the knowledge management process, 
showed as a nuclear process, takes advantage and 
updates the information generated (or acquired) from 
external sources (concerning to clinical practice or the 
research and development activities) as well as the 
data treatment from the organizational data reposito-
ries. Thus, the generated information could be used 
to support the organizational strategies related with 
its human or structural capital. Because it is not the 
purpose of this work analyzing or treating about orga-
nizational development, the authors avoid go into this 
topic in any depth).  Nonetheless, figure 2 shows the 
way in which the above mentioned processes can be 
integrated to suitably increase efficiency and operative 
effectiveness, as well as leading intellectual capital (or-
ganizational knowledge) to a measurable and sustaina-
ble competitive advantage for supporting the desired 
successes.
Because globalized activities oblige organizations to 
be alert to changes in the environment, to get an ho-
listic (or systemic) visualization, figure 3 shows inte-
ractions that organizations would maintain with the 
relational capital. Remembering that such interactions 
are fundamental for the organizational performance 
and, in consequence, these interactions must be con-
sidered in the organizational strategic planning. As it 
can be observed, besides integrating relational capital 
in the processes and results (taking advantage of the 
integration of computational, technical, and adminis-
trative systems), the proposed model would adapt 
properly with the organizational intentions, achieving 
a suitable leverage for the organizational performan-
ce. Hence,
Figure 2. Knowledge management process inserted in the proposed model (personal elaboration)
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Thus, it is convenient, and necessary, to develop a 
knowledge management system that takes advantage 
of information systems owned by the organization, in 
order to effectively support the decision making for 
Diabetes’ research and clinical processes related with 
both internal and external knowledge, as well as acqui-
red experiences from either experts or external sour-
ces related with the organization.
Conclusions
Though technology transference from industrialized 
countries to developing countries can be a funda-
mental condition for the technological development 
and businesses impulse for the developing coun-
tries;	 interests	 created	 by	 transnational	 companies	
and the lack of systemic vision of governors, have 
caused disinterest in establishing mechanisms adap-
ted for suitable in-sourcing and operation of external 
knowledge. Also, conditions are needed to encoura-
ge creation of new knowledge through knowled-
ge-bodies and knowledge-networks, developing 
constructive collaborations within knowledge limits, 
in order to optimize results and focus the efforts of 
scientific researchers in the development of systems 
and products adapted to the culture and necessities 
of their communities. In spite of this, Globalization 
puts in reach of regional scientific communities great 
volumes of information, which should be used and 
disseminated in an effective way to facilitate the suita-
ble use of this specific knowledge and to manage the 
accumulated organizational experience. Nowadays, 
it is possible to get methodologies, techniques, mo-
dels and robust tools that facilitate integration of 
information and knowledge into data repositories 
which could support strategic decision making, offe-
ring more advanced research fields corresponding to 
superior levels, such as fuzzy logic, data mining, neu-
ral and Bayesian networks, computational vision, and 
so on, as well as continuing the research and develo-
pment in disciplines such as bioengineering, medici-
ne, nanotechnology, accounting, and so on.
Figure 3. A holistic vision of the Knowledge Management System Model Proposed (personal elaboration)
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It is convenient to mention that long-term economic 
growth is linked with innovation capacity and techno-
logical productivity. Thanks to the social, economic 
and environmental benefits obtained by means of Bio-
technology, new possibilities emerge to direct world-
wide economy to a more sustainable development 
and a better life quality. Soon, artificial organs will be 
used (since genetic engineering involves a significant 
advance in the Science objectives and life-sciences). 
Thus Biotechnology, thanks to their social, economic 
and environmental potential, is going to be economi-
cally more important, setting up along with informa-
tion and communication technologies, the base of a 
new economy based on the “know and the know what 
to do” (know-how), such that conversion of know-how 
to competitive and sustainable processes, combined 
with R&D investments will be key success factors for 
the Knowledge Society. The systemic persistence of 
gaps between what is known and what practices im-
pact on the quality of services is one of the iniquity 
causes in health.   So, access to information and to 
up-to-date scientific knowledge constitutes a social de-
terminant for public health, leading scientific knowled-
ge transference in research, education, promotion or 
health attention systems as one of the critic problems 
for the global public health (BVS, 2009).
Therefore, with suitable management of knowledge-ba-
sed organizations (or communities), specific knowled-
ge is meant as the suitable use of organizational 
experience to increase and generate new knowledge 
on the basis of the generated information at its interior 
(or by means of the interchanges that these commu-
nities maintain with their surroundings), transforming 
it into measurable and sustainable competitive advan-
tages, that can be transformed into the awaited suc-
cesses. Camisón et al., (2006) mention that rapidity in 
the extension of enterprise knowledge is a fundamen-
tal issue in creating competitive advantages, besides 
the recognizing that most valuable knowledge for the 
company is that one which is characterized like tacit, 
condition that hinder its transmission outside the com-
pany limits. In this context, knowledge-based systems 
provide users with a set of robust tools for getting and 
describing metadata contents and their applications, 
besides to make easier the formal integration and re-
trieval of that data, for an adequate use of expertise or 
specific knowledge.
Taking into account the so-called scientific-
communication’s globalization (Gevers, 2009), as 
well as the maturity of artificial intelligence in medi-
cine (following the thought of Patel et al., 2008) and 
the developed work over clinical aspects for increa-
sing flexibility to related tasks, such as Kumar and 
Smith (2003) as well as Moser and Miksch (2005), or 
Groot et al., (2009) or Grando, Peleg and Glasspool 
(2010); this work proposes a model that takes advan-
tage of the knowledge-based system’s characteristics 
in order to support the clinical and research processes 
with either ripe decisions or up-to-the-minute scienti-
fic reports which lead the organizational strategies to 
maintain and establish improvement conditions for the 
specialized knowledge, including both the organizatio-
nal and the external expertise, such as is referred by 
Dormandy et al., (2005), or McGarry and Chambers 
and Oatley (2007), or Jenssen et al., (2008); besides 
the management of either technical or regulatory infor-
mation, as is treated by Steiness (2009).
As described in this work, knowledge-based systems 
are utilized for supporting biotechnological research 
processes as well as supporting tactical and strategic 
decisions. In spite of political or cultural rejections, 
thanks to Artificial Intelligence techniques and tools 
that knowledge-based systems exploit, and the evo-
lution of nanotechnical materials, Biotechnology can 
view the future with optimism. Thus, scientific commu-
nities from developing countries should only have to 
worry about getting economical conditions to develop 
their activities and projects, such as is suggested by 
Slingerland (2006) in her study about monogenic dia-
betes in children and young adults.
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Every two years since 1967 the mixing community meets to share and discuss the latest 
research and technology developments in mixing. Participants come from academia, 
industry, equipment manufacturers, private and government research institutions based in 
North America and all over the world. Mixing XXIII will take place in the Riviera Maya, Mexico, 
for the first time.  The conference this year includes an additional night enabling not only our 
scientific inquisitiveness to be cultivated, but also to nurture our souls by learning about the 
Mexican ancient culture that was able to have great achievements both in astronomy and 
mathematics. - Interestingly, the Mayan Culture also provided the world of its time with a highly 
sophisticated device for efficient mixing!
Come and join us in this most exciting conference. In June 2012 it will be held in the beautiful 
State of Quintana Roo, Mexico, in the heart of the Riviera Maya!




In keeping with the tradition of the conference, the acceptance of both oral and poster presentation is based - 
solely on submitted abstracts (300 – 600 words). Full papers are not required. 
There will be no published proceedings for the 
conference, which allows for the presentation and discussion of the most recent mixing research in a collegial 
environment.
Sessions will cover mixing related subjects from fundamentals to the application of mixing in a wide range of 
industrial processes. Topics include, but are not limited to:
  Mixing Fundamentals   New modeling and simulation approaches to mixing
  Mixing on small scales   Mixing and chemical reaction
  Static and Other in-Line Mixers   CFD Modeling of mixers and mixing processes
  Mixing of Multi-phase Systems   Mixing aspects of biotechnological processes
  Mixing of solids   Industrial Mixing Processes
A special session of Mixing XXIII will be devoted to celebrate the 21st anniversary of NAMF, discussing the 21 
most influential contributions to mixing.
Please e-mail your abstract submission to . You will 
receive an e-mail confirmation within the next 24 hours. If not, please contact Marcela García at the same e-
mail address. 
The deadline for the 







Short course on Mixing: June 17th
The Iberostar Paraíso Beach lies between Playa del Carmen and the lesser-known city of Puerto Morelos, 
which is some 15 minutes from Cancun International Airport. The contrast between these two cities is 
immediately noticeable: Puerto Morelos is a far more relaxed, laid-back destination, popular with artists and 
craftsmen, fishermen and divers. In contrast, the glamorous Playa del Carmen is far more lively and vibrant, 
and is packed with tourists who flock to the beaches during the day and in the evening enjoy a drink at one of 
the many bars. The hotel address is:
Carretera Chetumal - Puerto Juarez, km.309
Playa Paraíso, Quintana Roo –Mexico
Phone  +(52-984) 8772800
Fax: +(52-984) 8772810
Web site:  http://www.iberostar.com/EN/Riviera-Maya-hotels/Iberostar-Paraiso-Beach.html
For further information visit:  www.mixing.net • www.23mixing.net
For further information visit:  www.mixing.net • www.23mixing.net
The call for papers 
for Mixing XXIII is now open
For further information visit:  www.mixing.net • www.23mixing.net
The Iberostar Paraíso Beach is a family hotel built in 
traditional Mexican colonial style, with arches and columns 
throughout. The furniture in this All Inclusive hotel includes 
authentic works of art that wouldn't look out of place in an 
exhibition of fine art. Upon arrival at the hotel the superb 
wooden carvings in the reception area will immediately strike 
you. This is the perfect spot to escape from the crowds. The 
hotel is so large that a small train runs every 15 minutes 
transporting guests around the facilities to the restaurants, 
lobby, rooms and even the shopping mall and modern spa 
that form part of the Paraíso complex.
Hotel: Iberostar Paraiso Beach
As night falls on Xcaret, a fiesta awakens with the most famous 
musical performance in Mexico: Xcaret Mexico Espectacular. More 
than 300 artists on stage will amaze you with a vibrant musical 
journey through the history of Mexico, which brings to life colorful 
traditions and the heritage of the country
Xcaret Mexico Espectacular will take you to presence an 
unforgettable display of Mexican traditional hand-made dresses, 
dances and musical performances that will stay in your heart forever. 
This is the most amazing representation of Mexico's national identity 
and cultural heritage. Dinners are served while guests enjoy Xcaret 
Mexico Espectacular.
Dinner in XCARET is included in the program
Also included is a day-trip to Chichen Itza. It was the most important 
regional capital of the Mayan culture from 750 to 1200 B.C. Their 
structures are well conserved, as well as the Yucatan ancient 
Mayas tales.  Their vestiges show the incredible Mayan civilization 
and architecture, enriched with other cultural currents of 
Mesoamerica. The temple of Kukulcán, also called "El Castillo”, is a 
magnificent construction of 23 meters of height in pyramidal form.  
It has four faces, in which during the equinox a shade of a serpent 
can be seen descending by the stairs of the building.  You will also 
visit the Ball Game (the greatest of Mesoamerica), the 
Observatory, the Temple of the Soldiers with its figure of the Chac-
Mool and the sacred cenote.




BIOPARTNERING LATIN AMERICA 2012
INNOVACIÓN, NEGOCIOS Y GLOBALIZACIÓN
11 - 13 SEPTIEMBRE | RIO DE JANEIRO, RJ, BRASIL
PRODUCED BY:
QUÉ ES: Un evento para la industria de biotecnología y biociencias, centrado en la realización de reuniones 
de negocios entre los participantes, de presentaciones de empresas y de conferencias. 
OBJETIVOS: Proporcionar un entorno propicio para los participantes a ampliar sus contactos, fortalecer 
alianzas y establecer nuevos negocios. Presentar el potencial de las empresas de biotecnología y 
biociencias en América Latina.
MATCHMAKING: Un diferenciador clave del evento es la herramienta biopartnering.com, que permite la 
creación y difusión de perfiles individuales, de la empresa y sus productos, para programar con 
precedencia reuniones más efectivas con socios potenciales.
PÚBLICO: Estimado en 300 altos ejecutivos, que representan a los principales actores de la industria de 
biotecnología y biociencias.
En su tercera edición, BPL se consagra como uno de los eventos del segmento de más rápido crecimiento, 
siempre trayendo los líderes de la industria de biotecnología y biociencias, y que muestra, a través de 
conferencias y debates, las principales tendencias de este sector.
 
¡BioPartnering Latin America 2012 es su oportunidad de estar cara a cara con los grandes líderes de la 
industria farmacéutica, de biotecnología y los inversores de capital de riesgo! 
ESTRUCTURA DEL EVENTO
Reuniones de Negocios 
El BPL 2012, a través de la plataforma biopartnering.com, crea un ambiente para la realización de 
reuniones de negocios entre las personas adecuadas en un corto tiempo.
Presentaciones de Empresas
El BPL 2012 presentará empresas jóvenes y crecientes de varios países de América Latina, que podrán 
destacar sus productos y objetivos de asociación. Cada una de estas empresas estará disponible para 
reuniones presenciales luego después de sus presentaciones y al largo de todo el evento.
Sesiones de Liderazgo
Ejecutivos de las empresas de biotecnología y biociencias, representantes de los gobiernos y inversores de 
todo el mundo, hablarán, en conferencias, acerca de sus experiencias y predicciones del sector.
¡ÚNETE A LOS LÍDERES MUNDIALES 
EN BIOCIENCIAS Y BIOTECNOLOGÍA!
HECHOS Y CIFRAS DE EDICIONES PASADAS
¡PARTICIPE!
•  Acceso a un grupo selecto de participantes;
•  Oportunidad de conectarse con socios estratégicos;
•  Maximizar sus estrategias de creación de redes;
• Numerosas posibilidades para reuniones, sin restricciones en el número de invitaciones, 
        realizadas o recibidas;
•  Capacidad de hacer crecer su negocio a través de asociaciones;
• Posibilidad de planificar su participación y de organizar el calendario de reuniones, antes mismo 
      del comienzo del evento.
INFORMACIÓN E INSCRIPCIÓN:
+55 31 3303 0012
bpl@biominas.org.br
www.techvision.com/bpl
¡AQUÍ SE HACEN NEGOCIOS!
